Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST004042)

Reversed phase POSITIVE ION MODE (Analysis AN006681)

Metabolite	Structure	F1	F2
11-cis-Retinaldehyde	ME1075170	1.00	NA
4-Hydroxydebrisoquine	ME1075113	0.23	1.77
1-Nitronaphthalene-5,6-oxide	ME1075335	NA	1.00
2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid	ME1075166	1.00	NA
4-[(Hydroxymethyl)nitrosoamino]-1-(3-pyridinyl)-1-butanone	ME1075381	NA	1.00
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol	ME1075329	NA	1.00
1-Methylxanthine	ME1075152	1.00	NA
16a-Hydroxyandrost-4-ene-3,17-dione	ME1075253	0.98	1.02
19-Hydroxyandrost-4-ene-3,17-dione	ME1075251	0.58	1.42
19-Oxoandrost-4-ene-3,17-dione	ME1075283	1.09	0.91
2-Methoxyestradiol	ME1075250	0.91	1.09
2-Oxo-4-methylthiobutanoic acid	ME1075206	0.58	1.42
12(S)-HPETE	ME1075278	1.00	NA
3beta,7alpha-Dihydroxy-5-cholestenoate	ME1075186	1.00	NA
4-Guanidinobutanoic acid	ME1075196	1.00	NA
16b-Hydroxyestrone	ME1075290	1.00	NA
17-Hydroxyprogesterone	ME1075364	NA	1.00
17alpha,21-Dihydroxypregnenolone	ME1075247	1.00	NA
3a,7a,12a-Trihydroxy-5b-cholestan-26-al	ME1075323	NA	1.00
1-Naphthol	ME1075092	0.83	1.17
17-beta-Estradiol-3-glucuronide	ME1075256	1.29	0.85
2-Methoxyestrone	ME1075282	0.77	1.23
11,12,15-THETA	ME1075274	1.48	0.76
1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene	ME1075214	1.00	NA
2-Oxoarginine	ME1075178	1.00	NA
4a-Carboxy-4b-methyl-5a-cholesta-8,24-dien-3b-ol	ME1075311	NA	1.00
11H-14,15-EETA	ME1075269	1.00	NA
3,4-Dihydroxyphenylacetaldehyde	ME1075207	1.00	NA
11b,21-Dihydroxy-3,20-oxo-5b-pregnan-18-al	ME1075240	1.00	NA
21-Deoxycortisol	ME1075261	1.00	NA
3a,21-Dihydroxy-5b-pregnane-11,20-dione	ME1075248	1.00	NA
3-ketosphinganine	ME1075371	NA	1.00
1-Pyrroline-4-hydroxy-2-carboxylate	ME1075304	NA	1.00
4a-Hydroxytetrahydrobiopterin	ME1075298	NA	1.00
4-Hydroxy-4-(methylnitrosoamino)-1-(3-pyridinyl)-1-butanone	ME1075380	NA	1.00
12(R)-HPETE	ME1075277	1.00	NA
1-Nitronaphthalene-7,8-oxide	ME1075336	NA	1.00
3-Hydroxylidocaine	ME1075293	1.66	0.34
11b,17a,21-Trihydroxypreg-nenolone	ME1075239	1.00	NA
11,14,15-THETA	ME1075275	1.63	0.69
3a,7a-Dihydroxycoprostanic acid	ME1075324	NA	1.00
19-Oxotestosterone	ME1075252	0.73	1.27
20a-Dihydroprogesterone	ME1075194	1.00	NA
24-Hydroxycalcitriol	ME1075185	1.00	NA
2-Methoxy-estradiol-17b 3-glucuronide	ME1075320	NA	1.00
1,2-Dihydronaphthalene-1,2-diol	ME1075176	1.00	NA
2-(S-Glutathionyl)acetyl glutathione	ME1075356	NA	1.00
15(S)-HPETE	ME1075270	1.00	NA
15H-11,12-EETA	ME1075268	1.00	NA
11-cis-Retinol	ME1075045	1.00	NA
20-Hydroxy-leukotriene B4	ME1075279	0.91	1.09
3,4-Dihydroxyphenylglycol	ME1075031	1.27	0.73
3-Methoxy-4-hydroxyphenylglycolaldehyde	ME1075164	1.00	NA
2-Hydroxyestrone	ME1075289	1.00	NA
3beta-Hydroxypregn-5-en-20-one sulfate	ME1075314	NA	1.00

Factors:

F1	Sample source:wildtype \| Treatment:GFP
F2	Sample source:wildtype \| Treatment:P2_HNF4a

Data matrix